Sponsor:
California Retina Consultants
Code:
NCT02067013
Conditions
Proliferative Diabetic Retinopathy
Macular Degeneration
Macular Hole
Neovascular Glaucoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ranibizumab
No Ranibizumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-19. This information was provided to ClinicalTrials.gov by California Retina Consultants on 2017-03-01.